Abstract
Summary: Dihydropyrimidine dehydrogenase (DPD) deficiency is a rare autosomal recessive disorder of pyrimidine metabolism. Patients may present with a wide range of neurological symptoms during the first years of life. Head imaging abnormalities have been reported only rarely and include diffuse cerebral atrophy and white-matter hyperintensity. The pathogenesis of the white-matter abnormalities is unknown, although environmental factors and altered energy metabolism may be involved. To further understanding of the spectrum of brain abnormalities associated with DPD deficiency, we report a 17-month-old girl, born to a consanguineous Pakistani couple, who had a history of encephalopathy, prolonged hypoventilation, developmental delay and failure to thrive. Head MRI showed prominent sulci and abnormal T2 prolongation in the cerebral white matter and brainstem. Thus, DPD deficiency may feature prominent brain abnormalities involving the cerebral white matter and brainstem. Anoxic stress may have contributed to the clinical presentation and brain findings in this case. In order to define more clearly the contribution of DPD deficiency to the pathogenesis of these MRI abnormalities, we recommend performing detailed analysis of urine pyrimidine metabolites in patients who have such findings.
Similar content being viewed by others
REFERENCES
Braakhekke JP, Renier WO, Gabreëls FJM, et al (1987) Dihydropyrimidine dehydrogenase deficiency: neurological aspects. J Neurol Sci 78: 71–77.
Christensen E, Cezanne I, Kjaergaard S, et al (1998) Clinical variability in three Danish patients with dihydropyrimidine dehydrogenase deficiency all homozygous for the same mutation. J Inherit MetabDis 21: 272–275.
Fiumara A, van Kuilenburg ABP, Caruso U, et al (2003) Dihydropyrimidine dehydrogenase deficiency and acute neurological presentation. J Inherit Metab Dis 26: 407–409.
Franco DA, Greenberg HS (2001) 5-FU multifocal inflammatory leukoencephalopathy and dihydropyrimidine dehydrogenase deficiency. Neurology 56: 110–112.
Heggie GD, Sommadossi J-P, Cross DS, et al (1987) Clinical pharmacokinetics of 5-fluorouracil and its metabolism in plasma, urine, and bile. Cancer Res 47: 2203–2206.
Holopainen I, Pulkki K, Heinonen OJ, et al (1997) Partial epilepsy in a girl with a symptom-free sister: first two Finnish patients with dihydropyrimidine dehydrogenase deficiency. J Inherit Metab Dis 20: 719–720.
Savoiardo M, Zeviani M, Uziel G, Farina L (2001) MRI in Leigh syndrome with SURF1 gene mutation. Ann Neurol 49: 138–139.
van der Knaap MJ, Valk J (1995) Magnetic Resonance of Myelin, Myelination, and Myelin Disorders, 2nd edn.Berl in: Springer-Verlag.
van Gennip AH, Busch S, Elzinga L, et al (1993) Application of simple chromatographic methods for the diagnosis of defects in pyrimidine degradation. Clin Chem 39: 380–385.
van Gennip AH, Abeling NGGM, Vreken P, et al (1997) Inborn errors of pyrimidine degradation: clinical, biochemical and molecular aspects. J Inherit MetabDis 20: 203–213.
van Kuilenburg ABP, Abeling NGGM, Bakker HD, et al (1999a) Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency. Hum Genet 104: 1–9.
van Kuilenburg ABP, Vreken P, Riva D, et al (1999b) Clinical and biochemical abnormalities in a patient with dihydropyrimidine dehydrogenase deficiency due to homozygosity for the C29R mutation. J Inherit Metab Dis 22: 191–192.
van Kuilenburg ABP, Dobritzsch D, Meinsma R, et al (2002) Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimensional protein structure. Biochem J 364: 157–163.
van Kuilenburg ABP, Stroomer AEM, van Lenthe H, Abeling NGGM, van Gennip AH (2004) New insights to dihydropyrimidine dehydrogenase deficiency.A pivotal role for b-aminoisobutyric acid? Biochem J 379: 119–124.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Enns, G.M., Barkovich, A.J., van Kuilenburg, A.B.P. et al. Head imaging abnormalities in dihydropyrimidine dehydrogenase deficiency. J Inherit Metab Dis 27, 513–522 (2004). https://doi.org/10.1023/B:BOLI.0000037350.24142.d5
Issue Date:
DOI: https://doi.org/10.1023/B:BOLI.0000037350.24142.d5